This Week's Risk Radar: What RaymondsIndex Is Watching — When a Stock Dies in Silence
1. The news. This Monday, July 6, marks the endgame for UTILEX, a KOSDAQ-listed immunotherapy developer. Its shares have not traded since February 9, when auditors issued a disclaimer of opinion on the 2025 financial statements, citing going-concern uncertainty and a scope limitation. The audit report showed current liabilities exceeding current assets by KRW 12.3 billion. On July 2, the Korea Exchange confirmed delisting for July 15, with liquidation trading scheduled to begin July 6 — and the company answered with an injunction filing that froze trading entirely. On the same day, another KOSDAQ name, Incredible Buzz, entered its own trading suspension. And in Sydney, WiseTech Global — one of Australia's flagship tech companies — shed roughly 12% in a single session in late June after reports that federal police are investigating its founder-chairman, who remains the largest shareholder while a separate regulatory review examines his share trades during a 2025 blackout period. 2....